Call +1 (833) 552-7181 or Contact us Earn $25 in coupons on your first order with Aladdin!
Toggle Nav
My Cart
Search
Advanced Search
Menu
Sign In
྾
main product photo

Mycophenolic acid - 98%, high purity , Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor, CAS No.24280-93-1, Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor

2 Citations
Item Number
M110918
Grouped product items
SKUSizeAvailabilityPrice Qty
M110918-50mg
50mg
Available within 8-12 weeks(?)
Production requires sourcing of materials. We appreciate your patience and understanding.
$9.90
M110918-250mg
250mg
In stock
$38.90
M110918-1g
1g
Available within 4-8 weeks(?)
Items will be manufactured post-order and can take 4-8 weeks. Thank you for your patience!
$127.90
M110918-5g
5g
In stock
$576.90
M110918-10g
10g
Available within 4-8 weeks(?)
Items will be manufactured post-order and can take 4-8 weeks. Thank you for your patience!
$1,036.90
M110918-25g
25g
Available within 4-8 weeks(?)
Items will be manufactured post-order and can take 4-8 weeks. Thank you for your patience!
$2,332.90
M110918-100g
100g
Available within 4-8 weeks(?)
Items will be manufactured post-order and can take 4-8 weeks. Thank you for your patience!
$8,398.90
M110918-500g
500g
Available within 4-8 weeks(?)
Items will be manufactured post-order and can take 4-8 weeks. Thank you for your patience!
$37,791.90
Add to Wish List Compare
Bulk Order  SDS  DATASHEET

Immunosuppressant. Inosine monophosphate dehydrogenase inhibitor.

View related series
Anti-infection Antibiotic Bacterial Endogenous Metabolite Fungal inosine monophosphate dehydrogenase 1 Inhibitor inosine monophosphate dehydrogenase 2 Inhibitor Metabolic Enzyme/Protease

Basic Description

Synonyms(4E)-6-(4-hydroxy-6-methoxy-7-methyl-3-oxo-1,3-dihydro-2-benzofuran-5-yl)-4-methylhex-4-enoic acid | DTXCID4028882 | DTXCID2021070 | Lilly 68618 | (4E)-6-(4-Hydroxy-6-methoxy-7-methyl-3-oxo-1,3-dihydroisobenzofuran-5-yl)-4-methylhex-4-enoic Acid; Mycophen
Specifications & PurityMoligand™, ≥98%
Biochemical and Physiological MechanismsPotent inosine monophosphate dehydrogenase inhibitor (IMPDH) (K i values are 11 and 6 nM at IMPDH type I and II, respectively). Decreases RNA and DNA synthesis. Immunosuppressive agent. Shows antiviral and antitumor effects in vitro and in vivo .
Storage TempStore at -20°C
Shipped InIce chest + Ice pads
GradeMoligand™
Action TypeINHIBITOR
Mechanism of actionInosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor
NoteWherever possible, you should prepare and use solutions on the same day. However, if you need to make up stock solutions in advance, we recommend that you store the solution as aliquots in tightly sealed vials at -20°C. Generally, these will be useable for up to one month. Before use, and prior to opening the vial we recommend that you allow your product to equilibrate to room temperature for at least 1 hour. Need more advice on solubility, usage and handling? Please visit our frequently asked questions (FAQ) page for more details.
Product Description

Mycophenolic acid is a potent IMPDH inhibitor and the active metabolite of an immunosuppressive drug, used to prevent rejection in organ transplantation.

Product Properties

ALogP3.2

Associated Targets(Human)

IMPDH2 Tclin Inosine-5'-monophosphate dehydrogenase 2 (24 Activities)
Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)
IMPDH1 Tclin Inosine-5'-monophosphate dehydrogenase 1 (13 Activities)
Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)
PDE5A Tclin Phosphodiesterase 5A (5113 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
EGFR Tclin Epidermal growth factor receptor erbB1 (33727 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CA2 Tclin Carbonic anhydrase II (17698 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ESR1 Tclin Estrogen receptor alpha (17718 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HMGCR Tclin HMG-CoA reductase (2475 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
NR3C1 Tclin Glucocorticoid receptor (14987 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
INSR Tclin Insulin receptor (5558 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PGR Tclin Progesterone receptor (8562 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ADRB2 Tclin Beta-2 adrenergic receptor (11824 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CHRM2 Tclin Muscarinic acetylcholine receptor M2 (10671 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ADRB1 Tclin Beta-1 adrenergic receptor (6630 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HTR1A Tclin Serotonin 1a (5-HT1a) receptor (14969 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ADRA2A Tclin Alpha-2a adrenergic receptor (9450 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
AR Tclin Androgen Receptor (11781 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CHRM1 Tclin Muscarinic acetylcholine receptor M1 (12690 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
IMPDH2 Tclin Inosine-5'-monophosphate dehydrogenase 2 (1326 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ACE Tclin Angiotensin-converting enzyme (1423 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
DRD2 Tclin Dopamine D2 receptor (23596 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
IMPDH1 Tclin Inosine-5'-monophosphate dehydrogenase 1 (221 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MAOA Tclin Monoamine oxidase A (11911 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CNR1 Tclin Cannabinoid CB1 receptor (20913 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
DRD1 Tclin Dopamine D1 receptor (9720 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
DRD4 Tchem Dopamine D4 receptor (7907 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ACHE Tclin Acetylcholinesterase (18204 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PTGS1 Tclin Cyclooxygenase-1 (9233 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
SLC6A2 Tclin Norepinephrine transporter (10102 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HRH2 Tclin Histamine H2 receptor (5428 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ADRA1D Tclin Alpha-1d adrenergic receptor (4171 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HTR1B Tclin Serotonin 1b (5-HT1b) receptor (2801 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HTR2A Tclin Serotonin 2a (5-HT2a) receptor (14758 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HTR2C Tclin Serotonin 2c (5-HT2c) receptor (11471 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ADORA1 Tclin Adenosine A1 receptor (17603 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CALCR Tclin Calcitonin receptor (2215 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
SLC6A4 Tclin Serotonin transporter (12625 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ADRA1A Tclin Alpha-1a adrenergic receptor (8359 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PTGS2 Tclin Cyclooxygenase-2 (13999 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HRH1 Tclin Histamine H1 receptor (7573 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ADRA1B Tclin Alpha-1b adrenergic receptor (2912 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
OPRM1 Tclin Mu opioid receptor (19785 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
DRD3 Tclin Dopamine D3 receptor (14368 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PPARG Tclin Peroxisome proliferator-activated receptor gamma (15191 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
AVPR1A Tclin Vasopressin V1a receptor (5412 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
OPRD1 Tclin Delta opioid receptor (15096 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
OPRK1 Tclin Kappa opioid receptor (16155 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
SLC6A3 Tclin Dopamine transporter (10535 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
KCNH2 Tclin HERG (29587 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HTR4 Tclin Serotonin 4 (5-HT4) receptor (2068 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ESR2 Tclin Estrogen receptor beta (9272 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CYSLTR1 Tclin Cysteinyl leukotriene receptor 1 (2118 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ERBB2 Tclin Receptor protein-tyrosine kinase erbB-2 (7851 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Agtr2 Angiotensin II type 2 (AT-2) receptor (803 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Mc4r Melanocortin receptor 4 (1205 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Ltc4s Leukotriene C4 synthase (1 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Sigmar1 Sigma opioid receptor (160 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Ttr Transthyretin (14 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Npy1r Neuropeptide Y receptor type 1 (8 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Cckar Cholecystokinin A receptor (90 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
guaB Inosine-5'-monophosphate dehydrogenase (49 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Nos2 Nitric oxide synthase, inducible (3573 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Mapk1 MAP kinase ERK2 (650 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Hdac6 Histone deacetylase 6 (222 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Mmp9 Matrix metalloproteinase 9 (38 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HD1 Histone deacetylase (38 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Chlamydia pneumoniae (241 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Pseudomonas aeruginosa (123386 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Klebsiella pneumoniae (43867 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Staphylococcus aureus (210822 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Acinetobacter baumannii (41033 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Escherichia coli (133304 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Mycobacterium tuberculosis (203094 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Saccharomyces cerevisiae (19171 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Mycobacterium intracellulare (1532 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Aspergillus fumigatus (16427 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Plasmodium falciparum (966862 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Cryptococcus neoformans (21258 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Candida albicans (78123 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Toxoplasma gondii (4585 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Plasmodium berghei (192651 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Human respirovirus 3 (1674 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Human orthopneumovirus (392 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Mus musculus (284745 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Rattus norvegicus (775804 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Cowpox virus (428 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Vaccinia virus (4609 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Human alphaherpesvirus 1 (11089 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Human immunodeficiency virus 1 (70413 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Coxsackievirus B3 (1096 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Coxsackievirus B5 (476 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Poliovirus 1 (1274 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Reovirus sp. (323 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Sindbis virus (1599 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
West Nile virus (623 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Yellow fever virus (1530 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Hepatitis C virus (23859 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Vesicular stomatitis virus (4460 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Punta Toro virus (1491 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Coxsackievirus B4 (2249 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Respiratory syncytial virus (3434 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
3T3-L1 (3664 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
BHK-21 (725 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Names and Identifiers

IUPAC Name (E)-6-(4-hydroxy-6-methoxy-7-methyl-3-oxo-1H-2-benzofuran-5-yl)-4-methylhex-4-enoic acid
INCHI InChI=1S/C17H20O6/c1-9(5-7-13(18)19)4-6-11-15(20)14-12(8-23-17(14)21)10(2)16(11)22-3/h4,20H,5-8H2,1-3H3,(H,18,19)/b9-4+
InChi Key HPNSFSBZBAHARI-RUDMXATFSA-N
Canonical SMILES CC1=C2COC(=O)C2=C(C(=C1OC)CC=C(C)CCC(=O)O)O
Isomeric SMILES CC1=C2COC(=O)C2=C(C(=C1OC)C/C=C(\C)/CCC(=O)O)O
WGK Germany 3
RTECS MP8050000
PubChem CID 446541
Molecular Weight 320.34
Beilstein 1295848
Reaxy-Rn 318158

Certificates

Certificate of Analysis(COA)

Enter Lot Number to search for COA:

Find and download the COA for your product by matching the lot number on the packaging.

17 results found

Lot NumberCertificate TypeDateItem
H2428041Certificate of AnalysisAug 31, 2024 M110918
L2307151Certificate of AnalysisSep 22, 2023 M110918
E2410018Certificate of AnalysisSep 22, 2023 M110918
L2125380Certificate of AnalysisSep 22, 2023 M110918
L2125257Certificate of AnalysisSep 22, 2023 M110918
L2125256Certificate of AnalysisSep 22, 2023 M110918
L2125255Certificate of AnalysisSep 22, 2023 M110918
L2125254Certificate of AnalysisSep 22, 2023 M110918
L2125253Certificate of AnalysisSep 22, 2023 M110918
L2125252Certificate of AnalysisSep 22, 2023 M110918
J2317063Certificate of AnalysisSep 22, 2023 M110918
J2317051Certificate of AnalysisSep 22, 2023 M110918
J2317032Certificate of AnalysisSep 22, 2023 M110918
L1909151Certificate of AnalysisJun 05, 2023 M110918
J1922182Certificate of AnalysisMay 09, 2023 M110918
J1922180Certificate of AnalysisMay 09, 2023 M110918
L2008195Certificate of AnalysisSep 21, 2022 M110918

Show more⌵

Chemical and Physical Properties

SolubilitySoluble in methanol at 50mg/ml
SensitivityHeat sensitive
Melt Point(°C)141-145℃

Safety and Hazards(GHS)

Pictogram(s) GHS08,   GHS09,   GHS07
Signal Danger
Hazard Statements

H341:Suspected of causing genetic defects

H302:Harmful if swallowed

H400:Very toxic to aquatic life

H410:Very toxic to aquatic life with long lasting effects

H372:Causes damage to organs through prolonged or repeated exposure

H360:May damage fertility or the unborn child

Precautionary Statements

P273:Avoid release to the environment.

P280:Wear protective gloves/protective clothing/eye protection/face protection.

P405:Store locked up.

P501:Dispose of contents/container to ...

P264:Wash hands [and …] thoroughly after handling.

P260:Do not breathe dust/fume/gas/mist/vapors/spray.

P281:Use personal protective equipment as required.

P270:Do not eat, drink or smoke when using this product.

P391:Collect spillage.

P330:Rinse mouth.

P203:Obtain, read and follow all safety instructions before use.

P301+P317:IF SWALLOWED: Get medical help.

P318:if exposed or concerned, get medical advice.

P319:Get medical help if you feel unwell.

WGK Germany 3
RTECS MP8050000
Reaxy-Rn 318158
Merck Index 6327

Related Documents

 SDS

 Specification Sheet

Citations of This Product

How to Cite Aladdin Scientific Products?
1. Xiangli He, Jiayan Cui, Hui Ma, Naijipu Abuduaini, Ying Huang, Lu Tang, Wanyan Wang, Yuanyuan Zhang, Yang Wang, Weiqiang Lu, Bo Feng, Jin Huang.  (2023)  Berberrubine is a novel and selective IMPDH2 inhibitor that impairs the growth of colorectal cancer.  BIOCHEMICAL PHARMACOLOGY,  218  (15): (115868).  [PMID:37871880] [10.1016/j.bcp.2023.115868]
2. Lili Wu, Yulian Chen, Han Liu, Zhikun Zhan, Zhi Liang, Tao Zhang, Zheng Cai, Ling Ye, Menghua Liu, Jie Zhao, Shuwen Liu, Lan Tang.  (2018)  Emodin-induced hepatotoxicity was exacerbated by probenecid through inhibiting UGTs and MRP2.  TOXICOLOGY AND APPLIED PHARMACOLOGY,  359  (91).  [PMID:30248416] [10.1016/j.taap.2018.09.029]

References

1. Prado-Prado FJ, Martinez de la Vega O, Uriarte E, Ubeira FM, Chou KC, González-Díaz H.  (2009)  Unified QSAR approach to antimicrobials. 4. Multi-target QSAR modeling and comparative multi-distance study of the giant components of antiviral drug-drug complex networks..  Bioorg Med Chem,  17  (2): (569-75).  [PMID:19112024] [10.1021/op500134e]
2. Santana L et al..  (2008)  Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors..  J Med Chem,  51  (21): (6740-51).  [PMID:18834112]
3. William J Watkins,James M Chen,Aesop Cho,Lee Chong,Nicole Collins,Maria Fardis,Wei Huang,Magdeleine Hung,Thorsten Kirschberg,William A Lee,Xiaohong Liu,William Thomas,Jie Xu,Ameneh Zeynalzadegan,Jennifer Zhang.  (2006-04-20)  Phosphonic acid-containing analogues of mycophenolic acid as inhibitors of IMPDH..  Bioorganic & medicinal chemistry letters,  16  ((13)): (3479-3483).  [PMID:16621550]
4. Patricia M Stassen,Cees G M Kallenberg,Coen A Stegeman.  (2007-02-20)  Use of mycophenolic acid in non-transplant renal diseases..  Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association,  22  ((4)): (1013-1019).  [PMID:17307748]
5. Fawzy A Elbarbry,Ahmed S Shoker.  (2007-05-08)  Therapeutic drug measurement of mycophenolic acid derivatives in transplant patients..  Clinical biochemistry,  40  ((11)): (752-764).  [PMID:17482154]
6. Tiago L Moda,Carlos A Montanari,Adriano D Andricopulo.  (2007-09-18)  Hologram QSAR model for the prediction of human oral bioavailability..  Bioorganic & medicinal chemistry,  15  ((24)): (7738-7745).  [PMID:17870541]
7. Liqiang Chen,Guangyao Gao,Krzysztof Felczak,Laurent Bonnac,Steven E Patterson,Daniel Wilson,Eric M Bennett,Hiremagalur N Jayaram,Lizbeth Hedstrom,Krzysztof W Pankiewicz.  (2007-10-26)  Probing binding requirements of type I and type II isoforms of inosine monophosphate dehydrogenase with adenine-modified nicotinamide adenine dinucleotide analogues..  Journal of medicinal chemistry,  50  ((23)): (5743-5751).  [PMID:17958343]
8. Chung-Kyu Ryu,Ra-Young Lee,Seung-Yon Lee,Hwa-Jin Chung,Sang Kook Lee,Kwang-Hoe Chung.  (2008-04-11)  Design, synthesis and evaluation of 2-phenyl-1H-benzo[d]imidazole-4,7-diones as vascular smooth muscle cell proliferation inhibitors..  Bioorganic & medicinal chemistry letters,  18  ((9)): (2948-2951).  [PMID:18400498]
9. Sébastien Storck,Marc Thiry,Philippe Bouvet.  (2008-07-22)  Conditional knockout of nucleolin in DT40 cells reveals the functional redundancy of its RNA-binding domains..  Biology of the cell,  101  ((3)): (153-167).  [PMID:18637790]
10. Nicole K Bruchet,Mary H H Ensom.  (2009-08-20)  Limited sampling strategies for mycophenolic acid in solid organ transplantation: a systematic review..  Expert opinion on drug metabolism & toxicology,  5  ((9)): (1079-1097).  [PMID:19689217]
11. Andrew J Stevens,Michelle E Gahan,Suresh Mahalingam,Paul A Keller.  (2009-09-11)  The medicinal chemistry of dengue fever..  Journal of medicinal chemistry,  52  ((24)): (7911-7926).  [PMID:19739651]
12. Michele Tonelli,Matteo Simone,Bruno Tasso,Federica Novelli,Vito Boido,Fabio Sparatore,Giuseppe Paglietti,Sabrina Pricl,Gabriele Giliberti,Sylvain Blois,Cristina Ibba,Giuseppina Sanna,Roberta Loddo,Paolo La Colla.  (2010-04-03)  Antiviral activity of benzimidazole derivatives. II. Antiviral activity of 2-phenylbenzimidazole derivatives..  Bioorganic & medicinal chemistry,  18  ((8)): (2937-2953).  [PMID:20359898]
13. Maria-Dolores Fernandez-Garcia,Laurent Meertens,Matteo Bonazzi,Pascale Cossart,Fernando Arenzana-Seisdedos,Ali Amara.  (2010-12-31)  Appraising the roles of CBLL1 and the ubiquitin/proteasome system for flavivirus entry and replication..  Journal of virology,  85  ((6)): (2980-2989).  [PMID:21191016]
14. Burkhard Tönshoff,Elias David-Neto,Robert Ettenger,Guido Filler,Teun van Gelder,Jens Goebel,Dirk R J Kuypers,Eileen Tsai,Alexander A Vinks,Lutz T Weber,Lothar Bernd Zimmerhackl.  (2011-04-02)  Pediatric aspects of therapeutic drug monitoring of mycophenolic acid in renal transplantation..  Transplantation reviews (Orlando, Fla.),  25  ((2)): (78-89).  [PMID:21454065]
15. Zhichao Liu,Qiang Shi,Don Ding,Reagan Kelly,Hong Fang,Weida Tong.  (2011-12-24)  Translating clinical findings into knowledge in drug safety evaluation--drug induced liver injury prediction system (DILIps)..  PLoS computational biology,  7  ((12)): (e1002310-e1002310).  [PMID:22194678]
16. Rene Antonio Cervantes-Castañeda,Luis Alonso Gonzalez-Gonzalez,Miguel Cordero-Coma,Taygan Yilmaz,C Stephen Foster.  (2013-02-26)  Combined therapy of cyclosporine A and mycophenolate mofetil for the treatment of birdshot retinochoroidopathy: a 12-month follow-up..  The British journal of ophthalmology,  97  ((5)): (637-643).  [PMID:23435191]
17. Masaki Fuyama,Hirokazu Ikeda,Keiichi Isoyama.  (2013-03-07)  [A case of focal segmental glomerulosclerosis with nephrotic syndrome after hematopoietic stem cell transplantatation for aplastic anemia]..  Nihon Jinzo Gakkai shi,  55  ((1)): (83-89).  [PMID:23461215]
18. E Kieslichova,M Rocen,D Merta,M Kudla,I Splichal,J Cap,O Viklicky,R Gürlich.  (2013-03-19)  The effect of immunosuppression on manifestations of sepsis in an animal model of cecal ligation and puncture..  Transplantation proceedings,  45  ((2)): (770-777).  [PMID:23498819]
19. Wolfgang Arns,Claudia Sommerer,Petra Glander,Toofan Ariatabar,Martina Porstner,Christoph May,Eva-Maria Paulus,Maria Shipkova,Wolfgang Fischer,Lutz Liefeldt,Ruth Hackenberg,Peter Schemmer,Sophie Domhan,Martin Zeier,Klemens Budde.  (2013-04-25)  A randomized trial of intensified vs. standard dosing for enteric-coated mycophenolate sodium in de novo kidney transplant recipients: results at 1 year..  Clinical nephrology,  79  ((6)): (421-431).  [PMID:23611518]
20. Yutaro Mori,Katsuhito Ihara,Wakaba Yamaguchi,Tetsuro Fujii,Takayuki Toda,Michio Nagata,Noriaki Matsui.  (2013-05-02)  [A case of combination therapy with MMF and steroids for idiopathic membranoproliferative glomerulonephritis]..  Nihon Jinzo Gakkai shi,  55  ((2)): (177-184).  [PMID:23631306]
21. Mahendra Atlani,Raj K Sharma,Amit Gupta.  (2013-05-04)  Basiliximab induction in renal transplantation: long-term outcome..  Saudi journal of kidney diseases and transplantation : an official publication of the Saudi Center for Organ Transplantation, Saudi Arabia,  24  ((3)): (473-479).  [PMID:23640617]
22. M A Alba,L F Flores-Suárez.  (2013-07-24)  Seven clinical conundrums in the treatment of ANCA-associated vasculitis..  Clinical and experimental rheumatology,  31  ((1 Suppl 75)): (S74-S83).  [PMID:23663685]
23. Gaetano Ciancio,Junichiro Sageshima,Edip Akpinar,Jeffrey J Gaynor,Linda Chen,Alberto Zarak,Lois Hanson,Lissett Tueros,Giselle Guerra,Adela Mattiazzi,Warren Kupin,David Roth,Camillo Ricordi,George W Burke.  (2013-08-02)  A randomized pilot study of donor stem cell infusion in living-related kidney transplant recipients receiving alemtuzumab..  Transplantation,  96  ((9)): (800-806).  [PMID:23903014]
24. Carlos Abud-Mendoza,Roberto González-Amaro.  (2013-08-15)  Are steroids required for induction therapy and relapses in lupus nephritis?.  Annals of the rheumatic diseases,  72  ((12)): (e29-e29).  [PMID:23942867]
25. Bruno Tedeschi,Laurent Arnaud,Miguel Hie,Alexis Mathian,Zahir Amoura.  (2013-09-05)  Successful treatment of combined proliferative and membranous lupus nephritis using a full corticosteroid-free regimen..  Annals of the rheumatic diseases,  73  ((2)): (474-475).  [PMID:24001887]
26. Sule Unal,Erdal Sag,Baris Kuskonmaz,Selman Kesici,Benan Bayrakci,Deniz C Ayvaz,Ilhan Tezcan,Dilek Yalnızoglu,Duygu Uckan.  (2013-12-07)  Successful treatment of severe myasthenia gravis developed after allogeneic hematopoietic stem cell transplantation with plasma exchange and rituximab..  Pediatric blood & cancer,  61  ((5)): (928-930).  [PMID:24307660]
27. Muhammad Qasim,Hazir Rahman,Raees Ahmed,Michael Oellerich,Abdul R Asif.  (2014-02-11)  Mycophenolic acid mediated disruption of the intestinal epithelial tight junctions..  Experimental cell research,  322  ((2)): (277-289).  [PMID:24509232]
28. Sara Rostas,Miae Kim,Steven Gabardi.  (2014-03-07)  Risk evaluation and mitigation strategies: a focus on the mycophenolic acid preparations..  Progress in transplantation (Aliso Viejo, Calif.),  24  ((1)): (33-36).  [PMID:24598563]
29. Yutaka Kimura,Chizu Fujimura,Yumiko Ito,Toshiya Takahashi,Setsuya Aiba.  (2014-03-08)  Evaluation of the Multi-ImmunoTox Assay composed of 3 human cytokine reporter cells by examining immunological effects of drugs..  Toxicology in vitro : an international journal published in association with BIBRA,  28  ((5)): (759-768).  [PMID:24603311]
30. Daniela Braida,Luisa Ponzoni,Roberta Martucci,Mariaelvina Sala.  (2014-04-01)  A new model to study visual attention in zebrafish..  Progress in neuro-psychopharmacology & biological psychiatry,  55  (80-86).  [PMID:24681194]
31. Anuksha Gujadhur,Napier Thomson,Ar Kar Aung,Catriona Mclean,Solomon Menahem.  (2014-05-16)  CMV sinusitis in a HIV-negative renal transplant recipient..  Transplantation,  97  ((9)): (e55-e57).  [PMID:24827770]
32. Marta Kruk-Słomka,Agnieszka Michalak,Barbara Budzyńska,Grażyna Biała.  (2014-06-21)  A comparison of mecamylamine and bupropion effects on memory-related responses induced by nicotine and scopolamine in the novel object recognition test in mice..  Pharmacological reports : PR,  66  ((4)): (638-646).  [PMID:24948066]
33. Phillip C Delekta,Craig J Dobry,Janice A Sindac,Scott J Barraza,Pennelope K Blakely,Jianming Xiang,Paul D Kirchhoff,Richard F Keep,David N Irani,Scott D Larsen,David J Miller.  (2014-07-18)  Novel indole-2-carboxamide compounds are potent broad-spectrum antivirals active against western equine encephalitis virus in vivo..  Journal of virology,  88  ((19)): (11199-11214).  [PMID:25031353]
34. Anna Sommansson,Wan Salman Wan Saudi,Olof Nylander,Markus Sjöblom.  (2014-07-18)  The ethanol-induced stimulation of rat duodenal mucosal bicarbonate secretion in vivo is critically dependent on luminal Cl-..  PloS one,  9  ((7)): (e102654-e102654).  [PMID:25033198]
35. Deshka Doycheva,Herbert Jägle,Manfred Zierhut,Christoph Deuter,Gunnar Blumenstock,Ulrich Schiefer,Katarina Stingl,Kai Januschowski,Bogomil Voykov,Nicole Stuebiger.  (2014-07-26)  Mycophenolic acid in the treatment of birdshot chorioretinopathy: long-term follow-up..  The British journal of ophthalmology,  99  ((1)): (87-91).  [PMID:25061107]
36. R Brian Stevens,Kirk W Foster,Clifford D Miles,James T Lane,Andre C Kalil,Diana F Florescu,John P Sandoz,Theodore H Rigley,Kathleen J Nielsen,Jill Y Skorupa,Anna M Kellogg,Tamer Malik,Lucile E Wrenshall.  (2014-08-02)  A randomized 2×2 factorial trial, part 1: single-dose rabbit antithymocyte globulin induction may improve renal transplantation outcomes..  Transplantation,  99  ((1)): (197-209).  [PMID:25083614]
37. .  (2014-11-11)  Summaries for patients. Multitarget therapy for induction treatment of lupus nephritis..  Annals of internal medicine,  162  ((1)): (I24-I24).  [PMID:25383607]
38. Sifei Han,Luojuan Hu,Tim Quach,Jamie S Simpson,Natalie L Trevaskis,Christopher J H Porter.  (2014-12-03)  Profiling the role of deacylation-reacylation in the lymphatic transport of a triglyceride-mimetic prodrug..  Pharmaceutical research,  32  ((5)): (1830-1844).  [PMID:25446770]
39. Matthew D Pauly,Adam S Lauring.  (2015-01-16)  Effective lethal mutagenesis of influenza virus by three nucleoside analogs..  Journal of virology,  89  ((7)): (3584-3597).  [PMID:25589650]
40. Ying Li,Guang Li,Benjamin Görling,Burkhard Luy,Jiulin Du,Jun Yan.  (2015-02-26)  Integrative analysis of circadian transcriptome and metabolic network reveals the role of de novo purine synthesis in circadian control of cell cycle..  PLoS computational biology,  11  ((2)): (e1004086-e1004086).  [PMID:25714999]
41. Yang Yang,Qian Tang,Ming Zhao,Gongping Liang,Haijing Wu,Duo Li,Yubing Xie,Yixin Tan,Yong Dai,Susan Yung,Tak Mao Chan,Qianjin Lu.  (2015-03-21)  The effect of mycophenolic acid on epigenetic modifications in lupus CD4+T cells..  Clinical immunology (Orlando, Fla.),  158  ((1)): (67-76).  [PMID:25791245]
42. Amandine Bonnet,Hugo Bretes,Benoit Palancade.  (2015-04-08)  Nuclear pore components affect distinct stages of intron-containing gene expression..  Nucleic acids research,  43  ((8)): (4249-4261).  [PMID:25845599]
43. A M Nagib,M H Abbas,M M Abu-Elmagd,A A E F Denewar,A H Neamatalla,A F Refaie,M A Bakr.  (2015-06-04)  Long-term study of steroid avoidance in renal transplant patients: a single-center experience..  Transplantation proceedings,  47  ((4)): (1099-1104).  [PMID:26036529]
44. Gerson Dierley Keppeke,S John Calise,Edward K L Chan,Luis Eduardo C Andrade.  (2015-07-15)  Assembly of IMPDH2-based, CTPS-based, and mixed rod/ring structures is dependent on cell type and conditions of induction..  Journal of genetics and genomics = Yi chuan xue bao,  42  ((6)): (287-299).  [PMID:26165495]
45. Yonghong Ding,Wenhui Shi,Guannan Xie,Ailan Yu,Qinghe Wang,Zongwang Zhang.  (2015-09-21)  CX3CR1 Mediates Nicotine Withdrawal-Induced Hyperalgesia via Microglial P38 MAPK Signaling..  Neurochemical research,  40  ((11)): (2252-2261).  [PMID:26386845]
46. Anne-Catherine Feutz,Christian De Geyter.  (2019-08-12)  Accuracy, discriminative properties and reliability of a human ESC-based in vitro toxicity assay to distinguish teratogens responsible for neural tube defects..  Archives of toxicology,  93  ((8)): (2375-2384).  [PMID:31401662]
47. J F Gummert,M J Barten,S W Sherwood,T van Gelder,R E Morris.  (1999-11-24)  Pharmacodynamics of immunosuppression by mycophenolic acid: inhibition of both lymphocyte proliferation and activation correlates with pharmacokinetics..  The Journal of pharmacology and experimental therapeutics,  291  ((3)): (1100-1112).  [PMID:10565830]
48. Tony K L Kiang,Mary H H Ensom,Thomas K H Chang.  (2005-03-23)  UDP-glucuronosyltransferases and clinical drug-drug interactions..  Pharmacology & therapeutics,  106  ((1)): (97-132).  [PMID:15781124]
49. John R Goodell,Francesc Puig-Basagoiti,Brett M Forshey,Pei-Yong Shi,David M Ferguson.  (2006-03-17)  Identification of compounds with anti-West Nile Virus activity..  Journal of medicinal chemistry,  49  ((6)): (2127-2137).  [PMID:16539402]
50. Neal M Davies,Josep Grinyó,Robert Heading,Bart Maes,Herwig-Ulf Meier-Kriesche,Michael Oellerich.  (2007-06-15)  Gastrointestinal side effects of mycophenolic acid in renal transplant patients: a reappraisal..  Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association,  22  ((9)): (2440-2448).  [PMID:17557774]
51. Markus Mezger,Iwona Wozniok,Christian Blockhaus,Oliver Kurzai,Holger Hebart,Hermann Einsele,Juergen Loeffler.  (2008-04-23)  Impact of mycophenolic acid on the functionality of human polymorphonuclear neutrophils and dendritic cells during interaction with Aspergillus fumigatus..  Antimicrobial agents and chemotherapy,  52  ((7)): (2644-2646).  [PMID:18426895]
52. Liqiang Chen,Riccardo Petrelli,Magdalena Olesiak,Daniel J Wilson,Nicholas P Labello,Krzysztof W Pankiewicz.  (2008-06-28)  Bis(sulfonamide) isosters of mycophenolic adenine dinucleotide analogues: inhibition of inosine monophosphate dehydrogenase..  Bioorganic & medicinal chemistry,  16  ((15)): (7462-7469).  [PMID:18583139]
53. Hylke de Jonge,Maarten Naesens,Dirk R J Kuypers.  (2009-06-19)  New insights into the pharmacokinetics and pharmacodynamics of the calcineurin inhibitors and mycophenolic acid: possible consequences for therapeutic drug monitoring in solid organ transplantation..  Therapeutic drug monitoring,  31  ((4)): (416-435).  [PMID:19536049]
54. Liqiang Chen,Daniel J Wilson,Yanli Xu,Courtney C Aldrich,Krzysztof Felczak,Yuk Y Sham,Krzysztof W Pankiewicz.  (2010-05-25)  Triazole-linked inhibitors of inosine monophosphate dehydrogenase from human and Mycobacterium tuberculosis..  Journal of medicinal chemistry,  53  ((12)): (4768-4778).  [PMID:20491506]
55. Gary S Hoffman.  (2013-03-12)  L52. Vasculitis treatment: is it time to change the standard of care for ANCA-associated vasculitis?.  Presse medicale (Paris, France : 1983),  42  ((4 Pt 2)): (643-650).  [PMID:23474045]
56. Jacqueline S Mourer,Eelco J P de Koning,Erik W van Zwet,Marko J K Mallat,Ton J Rabelink,Johan W de Fijter.  (2013-05-30)  Impact of late calcineurin inhibitor withdrawal on ambulatory blood pressure and carotid intima media thickness in renal transplant recipients..  Transplantation,  96  ((1)): (49-57).  [PMID:23715049]
57. Marie B Condon,Damien Ashby,Ruth J Pepper,H Terence Cook,Jeremy B Levy,Megan Griffith,Tom D Cairns,Liz Lightstone.  (2013-06-07)  Prospective observational single-centre cohort study to evaluate the effectiveness of treating lupus nephritis with rituximab and mycophenolate mofetil but no oral steroids..  Annals of the rheumatic diseases,  72  ((8)): (1280-1286).  [PMID:23740227]
58. Christopher J Yates,Spiros Fourlanos,Peter G Colman,Solomon J Cohney.  (2013-08-02)  Screening for new-onset diabetes after kidney transplantation: limitations of fasting glucose and advantages of afternoon glucose and glycated hemoglobin..  Transplantation,  96  ((8)): (726-731).  [PMID:23902993]
59. Anahita Adeli,Daniel A Drubach,Mary M Machulda.  (2013-10-01)  Resolution of neuropsychological and FDG-PET abnormalities in a patient with neuropsychiatric systemic lupus erythematosus..  Cognitive and behavioral neurology : official journal of the Society for Behavioral and Cognitive Neurology,  26  ((3)): (161-166).  [PMID:24077576]
60. Maria Gorgan,Bruno Bockorny,Michael Lawlor,John Volpe,Mary Fiel-Gan.  (2013-10-31)  Pulmonary hemorrhage with capillaritis secondary to mycophenolate mofetil in a heart-transplant patient..  Archives of pathology & laboratory medicine,  137  ((11)): (1684-1687).  [PMID:24168511]
61. Jonathan I Lake,Olga A Tusheva,Brittany L Graham,Robert O Heuckeroth.  (2013-11-13)  Hirschsprung-like disease is exacerbated by reduced de novo GMP synthesis..  The Journal of clinical investigation,  123  ((11)): (4875-4887).  [PMID:24216510]
62. Bhadran Bose,Earl D Silverman,Joanne M Bargman.  (2013-12-18)  Ten common mistakes in the management of lupus nephritis..  American journal of kidney diseases : the official journal of the National Kidney Foundation,  63  ((4)): (667-676).  [PMID:24332767]
63. Azza A K El-Sheikh,Jan B Koenderink,Alfons C Wouterse,Petra H H van den Broek,Vivienne G M Verweij,Rosalinde Masereeuw,Frans G M Russel.  (2014-02-04)  Renal glucuronidation and multidrug resistance protein 2-/ multidrug resistance protein 4-mediated efflux of mycophenolic acid: interaction with cyclosporine and tacrolimus..  Translational research : the journal of laboratory and clinical medicine,  164  ((1)): (46-56).  [PMID:24486136]
64. Evan J Lipson,Mabel A Bodell,Edward S Kraus,William H Sharfman.  (2014-02-05)  Successful administration of ipilimumab to two kidney transplantation patients with metastatic melanoma..  Journal of clinical oncology : official journal of the American Society of Clinical Oncology,  32  ((19)): (e69-e71).  [PMID:24493726]
65. Ron Ram,Corina Herscovici,Dikla Dahan,Moshe Israeli,Juliet Dreyer,Anat Peck,Ofer Shpilberg,Moshe Yeshurun.  (2014-06-19)  Tailoring the GVHD prophylaxis regimen according to transplantation associated toxicities-Substituting the 3rd dose of methotrexate to mycophenolate mofetil..  Leukemia research,  38  ((8)): (913-917).  [PMID:24939215]
66. Francesco Ceppi,Michel Duval,Pierre Teira,Roxane Therrien,Philippe Ovetchkine,Brigitte Mallette,Henrique Bittencourt.  (2014-07-01)  Calcineurin inhibitor-free graft-versus-host disease prophylaxis with sirolimus and mycophenolate mofetil in a second allogeneic stem cell transplantation for engraftment failure and rituximab-refractory Epstein-Barr virus-induced posttransplant lymphoproliferative disease..  Journal of pediatric hematology/oncology,  36  ((5)): (e319-e321).  [PMID:24977404]
67. Chang-Kwon Oh,Kyu Ha Huh,Jongwon Ha,Yeong Hoon Kim,Yong-Lim Kim,Yu Seun Kim.  (2014-07-02)  Safety and efficacy of the early introduction of everolimus with reduced-exposure cyclosporine a in de novo kidney recipients..  Transplantation,  99  ((1)): (180-186).  [PMID:24983307]
68. Rick E Bernardi,Rainer Spanagel.  (2014-09-07)  A two-injection protocol for nicotine sensitization..  Behavioural brain research,  275  (11-14).  [PMID:25192633]
69. Zhihong Liu,Haitao Zhang,Zhangsuo Liu,Changying Xing,Ping Fu,Zhaohui Ni,Jianghua Chen,Hongli Lin,Fuyou Liu,Yongcheng He,Yani He,Lining Miao,Nan Chen,Ying Li,Yong Gu,Wei Shi,Weixin Hu,Zhengzhao Liu,Hao Bao,Caihong Zeng,Minlin Zhou.  (2014-11-11)  Multitarget therapy for induction treatment of lupus nephritis: a randomized trial..  Annals of internal medicine,  162  ((1)): (18-26).  [PMID:25383558]
70. Carter W Daniels,Elizabeth Watterson,Raul Garcia,Gabriel J Mazur,Ryan J Brackney,Federico Sanabria.  (2015-02-01)  Revisiting the effect of nicotine on interval timing..  Behavioural brain research,  283  (238-250).  [PMID:25637907]
71. Xin Liu,Li Sheng,Manman Zhao,Jiaqi Mi,Zhihao Liu,Yan Li.  (2015-03-12)  In vitro glucuronidation of the primary metabolite of 10-chloromethyl-11-demethyl-12-oxo-calanolide A by human liver microsomes and its interactions with UDP-glucuronosyltransferase substrates..  Drug metabolism and pharmacokinetics,  30  ((1)): (89-96).  [PMID:25760535]
72. Shino Oikawa,Asuka Mano,Mitsue Iketani,Yoshihiko Kakinuma.  (2015-05-17)  Nicotinic receptor-dependent and -independent effects of galantamine, an acetylcholinesterase inhibitor, on the non-neuronal acetylcholine system in C2C12 cells..  International immunopharmacology,  29  ((1)): (31-35).  [PMID:25979761]
73. Lisa L Drewry,L David Sibley.  (2015-06-18)  Toxoplasma Actin Is Required for Efficient Host Cell Invasion..  mBio,  6  ((3)): (e00557-e00557).  [PMID:26081631]
74. Xiangli He, Jiayan Cui, Hui Ma, Naijipu Abuduaini, Ying Huang, Lu Tang, Wanyan Wang, Yuanyuan Zhang, Yang Wang, Weiqiang Lu, Bo Feng, Jin Huang.  (2023)  Berberrubine is a novel and selective IMPDH2 inhibitor that impairs the growth of colorectal cancer.  BIOCHEMICAL PHARMACOLOGY,  218  (15): (115868).  [PMID:37871880] [10.1016/j.bcp.2023.115868]
75. Lili Wu, Yulian Chen, Han Liu, Zhikun Zhan, Zhi Liang, Tao Zhang, Zheng Cai, Ling Ye, Menghua Liu, Jie Zhao, Shuwen Liu, Lan Tang.  (2018)  Emodin-induced hepatotoxicity was exacerbated by probenecid through inhibiting UGTs and MRP2.  TOXICOLOGY AND APPLIED PHARMACOLOGY,  359  (91).  [PMID:30248416] [10.1016/j.taap.2018.09.029]

Solution Calculators

Privacy Policy Website Terms of Use Return policy Terms and Conditions of Sale Cookie Policy Sales Policy
Products are chemical reagents for research use only and are not intended for human use. We do not sell to patients.
Copyright © 2023-present Aladdin Scientific Corp . All rights reserved.